Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy

K. Van Vaerenbergh, K. Van Laethem, E. Van Wijngaerden, J.C. Schmit, F. Schneider, L. Ruiz, B. Clotet, C. Verhofstede, F. Van Wanzeele, G. Muyldermans, P. Simons, L. Stuyver, Et alt.

Research output: Contribution to journalArticleResearch

13 Citations (Scopus)
Original languageEnglish
Pages (from-to)529-537
JournalAIDS Res. Hum. Retroviruses
Volume16
Publication statusPublished - 1 Jan 2000

Cite this